161 related articles for article (PubMed ID: 26643280)
21. Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle.
Brocke B; Armbruster D; Muller J; Hensch T; Jacob CP; Lesch KP; Kirschbaum C; Strobel A
Mol Psychiatry; 2006 Dec; 11(12):1106-12. PubMed ID: 17033630
[TBL] [Abstract][Full Text] [Related]
22. Genetic gating of human fear learning and extinction: possible implications for gene-environment interaction in anxiety disorder.
Lonsdorf TB; Weike AI; Nikamo P; Schalling M; Hamm AO; Ohman A
Psychol Sci; 2009 Feb; 20(2):198-206. PubMed ID: 19175757
[TBL] [Abstract][Full Text] [Related]
23. Failure to condition to a cue is associated with sustained contextual fear.
Baas JM; van Ooijen L; Goudriaan A; Kenemans JL
Acta Psychol (Amst); 2008 Mar; 127(3):581-92. PubMed ID: 18048004
[TBL] [Abstract][Full Text] [Related]
24. Early-life stress-induced anxiety-related behavior in adult mice partially requires forebrain corticotropin-releasing hormone receptor 1.
Wang XD; Labermaier C; Holsboer F; Wurst W; Deussing JM; Müller MB; Schmidt MV
Eur J Neurosci; 2012 Aug; 36(3):2360-7. PubMed ID: 22672268
[TBL] [Abstract][Full Text] [Related]
25. Dorsomedial Prefrontal Cortex Mediates the Impact of Serotonin Transporter Linked Polymorphic Region Genotype on Anticipatory Threat Reactions.
Klumpers F; Kroes MC; Heitland I; Everaerd D; Akkermans SE; Oosting RS; van Wingen G; Franke B; Kenemans JL; Fernández G; Baas JM
Biol Psychiatry; 2015 Oct; 78(8):582-9. PubMed ID: 25444169
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms, genes and treatment: Experimental fear conditioning, the serotonin transporter gene, and the outcome of a highly standardized exposure-based fear treatment.
Wannemueller A; Moser D; Kumsta R; Jöhren HP; Adolph D; Margraf J
Behav Res Ther; 2018 Aug; 107():117-126. PubMed ID: 29960126
[TBL] [Abstract][Full Text] [Related]
27. Human BDNF rs6265 polymorphism as a mediator for the generalization of contextual anxiety.
Andreatta M; Neueder D; Genheimer H; Schiele MA; Schartner C; Deckert J; Domschke K; Reif A; Wieser MJ; Pauli P
J Neurosci Res; 2019 Mar; 97(3):300-312. PubMed ID: 30402941
[TBL] [Abstract][Full Text] [Related]
28. Variation in the corticotropin-releasing hormone receptor 1 (CRHR1) gene modulates age effects on working memory.
Grimm S; Gärtner M; Fuge P; Fan Y; Weigand A; Feeser M; Aust S; Heekeren HR; Jacobs A; Heuser I; Bajbouj M
J Psychiatr Res; 2015 Feb; 61():57-63. PubMed ID: 25541005
[TBL] [Abstract][Full Text] [Related]
29. Corticotropin-releasing hormone system polymorphisms are associated with children's cortisol reactivity.
Sheikh HI; Kryski KR; Smith HJ; Hayden EP; Singh SM
Neuroscience; 2013 Jan; 229():1-11. PubMed ID: 23131710
[TBL] [Abstract][Full Text] [Related]
30. Effects of corticotropin-releasing hormone receptor 1 SNPs on major depressive disorder are influenced by sex and smoking status.
da Silva BS; Rovaris DL; Schuch JB; Mota NR; Cupertino RB; Aroche AP; Bertuzzi GP; Karam RG; Vitola ES; Tovo-Rodrigues L; Grevet EH; Bau CH
J Affect Disord; 2016 Nov; 205():282-288. PubMed ID: 27544317
[TBL] [Abstract][Full Text] [Related]
31. Brain activation during fear conditioning in humans depends on genetic variations related to functioning of the hypothalamic-pituitary-adrenal axis: first evidence from two independent subsamples.
Ridder S; Treutlein J; Nees F; Lang S; Diener S; Wessa M; Kroll A; Pohlack S; Cacciaglia R; Gass P; Schütz G; Schumann G; Flor H
Psychol Med; 2012 Nov; 42(11):2325-35. PubMed ID: 22410078
[TBL] [Abstract][Full Text] [Related]
32. Genetic moderation of interpersonal psychotherapy efficacy for low-income mothers with major depressive disorder: implications for differential susceptibility.
Cicchetti D; Toth SL; Handley ED
Dev Psychopathol; 2015 Feb; 27(1):19-35. PubMed ID: 25640828
[TBL] [Abstract][Full Text] [Related]
33. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
Bale TL; Contarino A; Smith GW; Chan R; Gold LH; Sawchenko PE; Koob GF; Vale WW; Lee KF
Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
[TBL] [Abstract][Full Text] [Related]
34. Interactions Between Anandamide and Corticotropin-Releasing Factor Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions.
Demers CH; Drabant Conley E; Bogdan R; Hariri AR
Biol Psychiatry; 2016 Sep; 80(5):356-62. PubMed ID: 26923505
[TBL] [Abstract][Full Text] [Related]
35. Novel developments in genetic and epigenetic mechanisms of anxiety.
Gottschalk MG; Domschke K
Curr Opin Psychiatry; 2016 Jan; 29(1):32-8. PubMed ID: 26575296
[TBL] [Abstract][Full Text] [Related]
36. Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1.
Refojo D; Schweizer M; Kuehne C; Ehrenberg S; Thoeringer C; Vogl AM; Dedic N; Schumacher M; von Wolff G; Avrabos C; Touma C; Engblom D; Schütz G; Nave KA; Eder M; Wotjak CT; Sillaber I; Holsboer F; Wurst W; Deussing JM
Science; 2011 Sep; 333(6051):1903-7. PubMed ID: 21885734
[TBL] [Abstract][Full Text] [Related]
37. Heart rate dynamics and behavioral responses during acute emotional challenge in corticotropin-releasing factor receptor 1-deficient and corticotropin-releasing factor-overexpressing mice.
Tovote P; Meyer M; Ronnenberg A; Ogren SO; Spiess J; Stiedl O
Neuroscience; 2005; 134(4):1113-22. PubMed ID: 16039799
[TBL] [Abstract][Full Text] [Related]
38. Human fear reconsolidation and allelic differences in serotonergic and dopaminergic genes.
Agren T; Furmark T; Eriksson E; Fredrikson M
Transl Psychiatry; 2012 Feb; 2(2):e76. PubMed ID: 22832813
[TBL] [Abstract][Full Text] [Related]
39. Genetic contributions of the serotonin transporter to social learning of fear and economic decision making.
Crişan LG; Pana S; Vulturar R; Heilman RM; Szekely R; Druğa B; Dragoş N; Miu AC
Soc Cogn Affect Neurosci; 2009 Dec; 4(4):399-408. PubMed ID: 19535614
[TBL] [Abstract][Full Text] [Related]
40. Family environment interacts with CRHR1 rs17689918 to predict mental health and behavioral outcomes.
Roy A; Laas K; Kurrikoff T; Reif A; Veidebaum T; Lesch KP; Harro J
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():45-51. PubMed ID: 29772307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
